Lupin appoints Mr. Mark D. McDade as new Independent Director

Lupin Limited (Lupin), global pharmaceutical company, announced the appointment of Mr. Mark D. McDade as an Independent Director effective January 28, 2021.

Mr. McDade is the co-Founder and Partner at Qiming Venture Partners, USA where he led several high-value investments in biotherapeutics, including cell and gene therapy and digital health. With a career spanning over 37 years, he has led and transformed global companies as well as founded and advanced Biotech companies.

Commenting on the appointment, Manju D. Gupta, Chairman, Lupin said, "We are delighted to welcome Mr. Mark D. McDade on Lupin's board. We are confident that his diverse experience across large, mid and development-stage companies across Specialty & Biologics, will help advance our growth journey."

Mr. McDade holds a B.A. in History from Dartmouth College and MBA from Harvard Business School.

Shares of LUPIN LTD. was last trading in BSE at Rs.988.3 as compared to the previous close of Rs. 1007.75. The total number of shares traded during the day was 152642 in over 7037 trades.

The stock hit an intraday high of Rs. 1010.25 and intraday low of 978.15. The net turnover during the day was Rs. 151433502.

Source : Equity Bulls

Keywords